Neogenomics, Inc.
NEO
$16.22
$0.382.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 50.14% | -27.87% | -37.22% | -45.98% | -32.46% |
| Total Depreciation and Amortization | -7.58% | -7.63% | -6.50% | -4.26% | -2.33% |
| Total Amortization of Deferred Charges | -42.97% | -8.77% | -31.47% | -19.21% | -6.91% |
| Total Other Non-Cash Items | -41.24% | 62.07% | 75.97% | 80.13% | 62.81% |
| Change in Net Operating Assets | -43.67% | 39.43% | 1.64% | 17.64% | 40.17% |
| Cash from Operations | 56.94% | 194.57% | -25.53% | -8.80% | 5,221.59% |
| Capital Expenditure | 11.49% | 31.19% | 34.22% | 15.84% | -10.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 92.27% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -67.72% | -73.73% | -64.65% | -64.33% | -72.76% |
| Cash from Investing | -35.04% | -1,205.61% | -195.96% | -132.37% | -124.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -31.28% | -- | -- | -5,031,325.00% | -2,236,088.89% |
| Issuance of Common Stock | -43.52% | -69.18% | -55.98% | -11.91% | -11.20% |
| Repurchase of Common Stock | -997.31% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -896.01% | 96.36% | 108.20% | -28.04% | -39.47% |
| Cash from Financing | 94.30% | -4,317.93% | -4,410.98% | -3,925.44% | -3,487.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 200.00% | -- | -- | -- | -- |
| Net Change in Cash | 95.42% | -1,500.92% | -945.68% | -454.91% | -403.53% |